{
  "drug_id": "M031",
  "generic_name": "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE",
  "brand_names": [
    "ZITUVIMET"
  ],
  "drug_class": "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
  "indications": [],
  "dosage_protocol": {
    "adult_dose": "500-1000mg",
    "pediatric_dose": null,
    "frequency": "twice daily",
    "duration": "chronic therapy",
    "timing": "with meals",
    "max_daily_dose": "2550mg"
  },
  "adverse_effects": [
    "Nausea",
    "Headache",
    "Constipation",
    "Vomiting",
    "Rash",
    "Edema",
    "Abdominal pain",
    "Diarrhea"
  ],
  "adverse_effect_management": [],
  "contraindications": {
    "allergies": [
      "Hypersensitivity to this medication"
    ],
    "existing_diseases": [
      {
        "disease_id": "TBD_KIDNEY",
        "adverse_effect": "May worsen kidney function"
      }
    ],
    "other_conditions": []
  },
  "drug_interactions": [
    {
      "drug_name_or_class": "diuretic",
      "effect": "May alter electrolyte balance"
    }
  ],
  "pregnancy_category": "category_B: Probably safe",
  "special_populations": {
    "pregnancy": "category_B: Probably safe",
    "breastfeeding": "Unknown",
    "pediatric": "Consult guidelines",
    "geriatric": "May need dose adjustment",
    "renal_impairment": "Monitor and adjust as needed",
    "hepatic_impairment": "Use with caution"
  }
}